Corient Private Wealth’s JLens 500 Jewish Advocacy U.S. ETF TOV Stock Holding History
Bought
Maintained
Sold
Other funds holding TOV
CA
NL
SHGA
MASUI
SC
TPW
Corient Private Wealth's TOV Position: Q1 2026 in Review
Corient Private Wealth reduced its JLens 500 Jewish Advocacy U.S. ETF (TOV) stake by 50% in Q1 2026, selling an estimated $1.14M and leaving 39,936 shares worth $1.09K. The position accounts for ﹤0.01% of the portfolio, ranked #2818.
Corient Private Wealth first reported a position in TOV in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.29M in Q4 2025. 22 funds tracked by Wall St. Rank hold TOV as of Q1 2026.
- Corient Private Wealth held 39,936 shares of JLens 500 Jewish Advocacy U.S. ETF worth $1.09K as of Q1 2026.
- Corient Private Wealth sold 39,936 JLens 500 Jewish Advocacy U.S. ETF shares in Q1 2026, an estimated $1.14M.
- JLens 500 Jewish Advocacy U.S. ETF made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #2818 holding.
- Corient Private Wealth first reported a position in JLens 500 Jewish Advocacy U.S. ETF in Q2 2025 and has held it in 4 quarters since.
- Corient Private Wealth's JLens 500 Jewish Advocacy U.S. ETF position peaked at $2.29M in Q4 2025.
- 22 funds tracked by Wall St. Rank held JLens 500 Jewish Advocacy U.S. ETF as of Q1 2026.
Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.